Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Radboud University extends Institutional Agreement with UFS
2017-11-28

Description: 2017 International  Tags: internationalisation, Radboud University, Netherlands, institutional, Economic and Management Sciences, EU Erasmus+ programme, Business School  

Photo: Pixabay

The Office for International Affairs, in collaboration with the Business School, recently hosted delegates from Radboud University in the Netherlands to expand the existing partnership between the University of the Free State (UFS) and Radboud University.

Prof Joris Knoben and Charissa van Mourik visited the UFS to renew the Collaboration Agreement into an Institutional Agreement. The collaboration between the two universities was initially formalised as a Collaboration Agreement in August 2014. 

Zenzele Mdletshe, Senior Officer: North-South Cooperation: Internationalisation, says, “This partnership has been successful in implementing student exchange mobility, with about four students from Radboud University participating in student exchange programmes at the UFS for a period of six months.” The Dean of the Faculty of Economic and Management Sciences, Prof Hendri Kroukamp, has also been part of an International Week Programme at the Radboud University for the past three years.

Exploring student exchange mobility through funding
The negotiations focused on extending the collaboration, as well as exploring opportunities to have exchange mobility from the UFS to Radboud University. “The agreement is to look into opening cooperation through funding models such as the EU Erasmus+ programme in order to overcome the financial challenges which hinder mobility of UFS students,” Mdletshe says.

Postgraduate programmes considered for future development
Radboud University is said to consider the waiving of all costs related to the participation of three UFS students in a two-week summer school programme at their campus. In addition to this discussion, the development of the postgraduate exchange programme, research collaborations, and future exploration of joint master’s degree programmes are also a possibility. 
“The participants agreed that the universities would explore external funding opportunities, specifically with a view to developing reciprocal PhD mobility,” Mdletshe says.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept